ODDITY Tech

ODD

Market cap $2.48B

Oddity combines high growth, profitability, and a data-driven advantage, differentiating it from traditional beauty brands and creating a compelling investment case. ODD leverages machine learning and direct-to-consumer models, fueling rapid revenue growth, high margins, and successful brand launches like IL MAKIAGE, SpoiledChild, and METHODIQ. After a 50% pullback, ODD trades at an attractive valuation. If growth continues, the risk-reward profile is favorable, and the stock is considered a 'Buy'.

Oddity's sales and profits are growing at an impressive clip. Management sees further gain ahead.

Oddity Tech Ltd. ( ODD ) Q3 2025 Earnings Call November 20, 2025 8:30 AM EST Company Participants Maria Lycouris Oran Holtzman - Co-Founder, CEO & Director Lindsay Mann - Global Chief Financial Officer Conference Call Participants Dara Mohsenian - Morgan Stanley, Research Division Anna Lizzul - BofA Securities, Research Division Youssef Squali - Truist Securities, Inc., Research Division Andrew Boone - Citizens JMP Securities, LLC, Research Division Cory Carpenter - JPMorgan Chase & Co, Research Division Ryan MacDonald - Needham & Company, LLC, Research Division Scott Schoenhaus - KeyBanc Capital Markets Inc., Research Division Bonnie Herzog - Goldman Sachs Group, Inc., Research Division Georgia Anderson - Evercore ISI Institutional Equities, Research Division Lauren Lieberman - Barclays Bank PLC, Research Division Brian Tanquilut - Jefferies LLC, Research Division Presentation Operator Good morning.

Oddity Tech (ODD) came out with quarterly earnings of $0.4 per share, beating the Zacks Consensus Estimate of $0.35 per share. This compares to earnings of $0.32 per share a year ago.

NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) -- ODDITY Tech Ltd. (NASDAQ: ODD) today announced its financial results for the third quarter ended September 30, 2025.

Oddity, the maker of Il Makiage and Spoiled Child, launched its third brand Methodiq, a telehealth platform for medical skincare. Methodiq will offer 28 new products, including creams, supplements and cosmetics, that address acne, hyperpigmentation and eczema and range in price from about $29 to around $59.

NEW YORK--(BUSINESS WIRE)--ODDITY Tech Ltd. (NASDAQ: ODD) today announced the launch of METHODIQ, a medical telehealth platform delivering customized, high-efficacy treatments powered by online diagnosis – without needing to go to a doctor's office or get lost in a drug store. METHODIQ reimagines medical care with science, world-class treatments and AI analysis to deliver the highest standards of care – accessible to everyone. The platform begins with dermatology treatments for acne, hyperpigme.

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.

Baron International Growth Fund gained 6.04% during the quarter, slightly underperforming its benchmark, the MSCI ACWI ex USA Index. Lynas Rare Earths' shares nearly doubled during the quarter as geopolitical and trade tensions underscored the strategic importance of supply sources outside China. Constellation Software, a holding company that owns and operates a large portfolio of vertical-market software businesses, detracted from performance.

During the third quarter of 2025, the U.S. Small Cap Growth Composite Portfolio returned 21.4% gross and 21.1% net of fees. Bloom Energy is a provider of solid oxide fuel cells that play a critical role in delivering clean, reliable, 'always on' power at scale. Oddity Tech is a digital beauty and wellness platform that uses AI and data science to develop and recommend personalized products based on unique skin type and color signatures.